Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1780-1785

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nieto, F. J.
Right arrow Articles by Szklo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nieto, F. J.
Right arrow Articles by Szklo, M.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1780-1785.)
© 1997 American Heart Association, Inc.


Articles

Cytomegalovirus Infection, Lipoprotein(a), and Hypercoagulability: An Atherogenic Link?

F. Javier Nieto; Paul Sorlie; George W. Comstock; Kenneth Wu; Erwin Adam; Joseph L. Melnick; ; Moyses Szklo

From the Department of Epidemiology, The Johns Hopkins University School of Hygiene and Public Health, Baltimore, Md (F.J.N., G.W.C., M.S.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (P.S.), Division of Hematology, University of Texas Medical School, Houston, Tex (K.W.), and the Division of Molecular Virology, Baylor College of Medicine, Houston, Tex (E.A., J.L.M.).

Abstract A link between cytomegalovirus (CMV) infection and atherosclerosis has been suggested by experimental, clinical, and epidemiologic studies. We investigated the association between CMV antibody titers in serum collected in 1974 in 300 adult residents in Washington County, Md, and hemostatic parameters in plasma collected in 1987 through 1989, when these individuals participated in the baseline examination of the Atherosclerosis Risk in Communities Study. The cross-sectional association of CMV serum antibodies and hemostatic parameters was also explored in another set of Atherosclerosis Risk in Communities cases and controls. In the longitudinal analyses, CMV titers in 1974 were directly associated with 1987 through 1989 plasma levels of von Willebrand factor, factor VIII, and protein C and negatively associated with activated partial thromboplastin time. In the cross-sectional analyses, CMV titers were directly related to antithrombin III and fibrinogen levels. When the association between CMV antibodies and atherosclerosis was examined in stratified analyses, a significant association was restricted to individuals with high levels of lipoprotein(a) and fibrinogen. These results are compatible with previous evidence suggesting that CMV virus might have procoagulant properties. The possible synergism of CMV infection and resulting hypercoagulability with reduced fibrinolysis due to increased lipoprotein(a) levels deserves further investigation.


Key Words: atherosclerosis • cytomegalovirus • fibrinogen • hemostasis • lipoprotein(a)




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
Honors and Awards * Bibliography of Peer-Reviewed Journal Articles
Am. J. Epidemiol., October 1, 2008; 168(7): 845 - 854.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. Zare, M. Magnusson, L. N. Mollers, T. Jin, A. Tarkowski, and M. Bokarewa
Single-stranded polyinosinic acid oligonucleotides trigger leukocyte production of proteins belonging to fibrinolytic and coagulation cascades
J. Leukoc. Biol., September 1, 2008; 84(3): 741 - 747.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Volanen, O. T. Raitakari, R. Vainionpaa, M. Arffman, J. Aarnisalo, S. Angle, K. Kallio, and O. Simell
Serum Lipid Profiles Poorly Correlate With Chlamydia pneumoniae, Helicobacter pylori, and Cytomegalovirus Seropositivity in Prospectively Followed-Up Healthy Children
Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 827 - 832.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
P Jousilahti, V Salomaa, V Rasi, E Vahtera, and T Palosuo
Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status
J Epidemiol Community Health, September 1, 2003; 57(9): 730 - 733.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
M. K. Froberg, N. Seacotte, and E. Dahlberg
Cytomegalovirus Seropositivity and Serum Total Cholesterol Levels in Young Patients
Ann. Clin. Lab. Sci., April 1, 2001; 31(2): 157 - 161.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Hoffmeister, D. Rothenbacher, G. Bode, K. Persson, W. Marz, M. A. Nauck, H. Brenner, V. Hombach, and W. Koenig
Current Infection With Helicobacter pylori, but Not Seropositivity to Chlamydia pneumoniae or Cytomegalovirus, Is Associated With an Atherogenic, Modified Lipid Profile
Arterioscler. Thromb. Vasc. Biol., March 1, 2001; 21(3): 427 - 432.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. D. Sorlie, F. J. Nieto, E. Adam, A. R. Folsom, E. Shahar, and M. Massing
A Prospective Study of Cytomegalovirus, Herpes Simplex Virus 1, and Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study
Arch Intern Med, July 10, 2000; 160(13): 2027 - 2032.
[Abstract] [Full Text] [PDF]